Feed Preview

Cancer Genomics (Keystone)

Cancer Genomics (Keystone) diagram by Alemar et al, PLOS One
Alemar et al, PLOS One

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Top 20 most recent papers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Marrow infiltrating regulatory T cells correlate with the presence of dysfunctional CD4+PD-1+ cells and inferior survival in patients with newly diagnosed multiple myeloma

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2020
Nouf AlrasheedKwee L Yong
6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2020
Linlin YangTerence M Williams
2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Whole-Exome Sequencing Analysis of the Progression from Non-Low Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2020
Fresia ParejaJorge S Reis-Filho
2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2020
Konrad H StopsackWassim Abida
16
The Yale Journal of Biology and Medicine

Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma

The Yale Journal of Biology and MedicineApril 1, 2020
Sara Yumeen, Michael Girardi
1
Indian Journal of Clinical Biochemistry : IJCB

Therapeutic Targets in Telomerase and Telomere Biology of Cancers

Indian Journal of Clinical Biochemistry : IJCBApril 1, 2020
Rajendra PrasadWajid Mohammad
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2020
Julian MarconEd Reznik
4
Cells

Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape

CellsApril 1, 2020
Carmen Salguero-ArandaEnrique de Álava
Experimental and Molecular Pathology

PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target

Experimental and Molecular PathologyMarch 30, 2020
Soudeh Ghafouri-FardMohammad Taheri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

The pharmacokinetic-pharmacodynamic (PKPD) relationships of AZD3229, a novel and selective inhibitor of cKIT, in a range of mouse xenograft models of GIST

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2020
Venkatesh Pilla ReddyRhys D O Jones

See more papers from this feed

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/cancer-genomics-keystone/f928f68c-ddb8-4875-a183-4d03bc545fde